Chinese Regulators Examine Xinxing's Blood Products for HIV

Bookmark
(Bloomberg) -- The National Medical Products Administration has demanded Shanghai regulators conduct on-site inspections at Shanghai Xinxing Medicine after receiving a report that an Intravenous Hu...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.